Trial Outcomes & Findings for Buoy Electrolyte Study on Hydration Status of Active Men and Women (NCT NCT05768789)

NCT ID: NCT05768789

Last Updated: 2025-05-14

Results Overview

Determined by subtracting the cumulative urine output from the total fluid load consumed

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

30 participants

Primary outcome timeframe

360 minutes after ingestion

Results posted on

2025-05-14

Participant Flow

All enrolled participants completed 3 separate visits in a crossover design, each visit consisting of a different intervention. All participants completed the visits and interventions in the same order as listed below.

Participant milestones

Participant milestones
Measure
Buoy Electrolyte Then Water Only Then Nuun Electrolyte
Visit 1 - Buoy Electrolyte: Buoy intervention amount is 4% of total body weight given in 16 divided doses over 4 hours. The goal is to give 600mg of Na+ over 4 hours while measuring urine output over 6 hours. Therefore, to safely achieve a total dose 600mg Na+ (6-fold increase from single dose) we will use 4 tsps (18 ml) of Buoy diluted in 1 L of water. Visit 2 - Water Alone: Water serves as a control. Participants will ingest the same quantity of water (1 L) at a rate of 6.25% of the calculated amount of water every 15 min for 4 hours. Visit 3 - Nuun Electrolyte Tablet: Nuun intervention given as 1L bolus and then free water in divided doses for a total of 4% total body weight. The goal is to give a one-time dose of Nuun (600mg Na+) at the start of the trial, diluted in 1L water to be consumed within 30 min (similar to prior published data, Pence 2020).
Visit 1 : Buoy Electrolyte
STARTED
30
Visit 1 : Buoy Electrolyte
COMPLETED
30
Visit 1 : Buoy Electrolyte
NOT COMPLETED
0
Visit 2: Water Only
STARTED
30
Visit 2: Water Only
COMPLETED
30
Visit 2: Water Only
NOT COMPLETED
0
Visit 3: Nuun Electrolyte
STARTED
30
Visit 3: Nuun Electrolyte
COMPLETED
30
Visit 3: Nuun Electrolyte
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
All Enrolled Participants
n=30 Participants
All enrolled participants completed 3 separate visits, each visit consisting of a different intervention. All participants completed the visits and interventions in the same order as listed below. Visit 1 - Buoy Electrolyte: Buoy intervention amount is 4% of total body weight given in 16 divided doses over 4 hours. The goal is to give 600mg of Na+ over 4 hours while measuring urine output over 6 hours. The recommended Buoy dosage is ⅓ tsp in 237 ml of water (50mg Na+) multiple times a day (Table 1). Therefore, to safely achieve a total dose 600mg Na+ (6-fold increase from single dose) we will use 4 tsps (18 ml) of Buoy diluted in 1 L of water. Visit 2 - Water Alone: Water serves as a control. Participants will ingest the same quantity of water (1 L) at a rate of 6.25% of the calculated amount of water every 15 min for 4 hours. Visit 3 - Nuun Electrolyte Tablet: Nuun intervention given as 1L bolus and then free water in divided doses for a total of 4% total body weight. The goal is to give a one-time dose of Nuun (600mg Na+) at the start of the trial, diluted in 1L water to be consumed within 30 min (similar to prior published data, Pence 2020).
Age, Categorical
<=18 years
0 Participants
n=30 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=30 Participants
Age, Categorical
>=65 years
0 Participants
n=30 Participants
Age, Continuous
29.9 Years
STANDARD_DEVIATION 5.6 • n=30 Participants
Sex: Female, Male
Female
16 Participants
n=30 Participants
Sex: Female, Male
Male
14 Participants
n=30 Participants
Region of Enrollment
United States
30 participants
n=30 Participants
Body Weight (kg)
82.6 kilograms
STANDARD_DEVIATION 16.9 • n=30 Participants
Body Mass Index (BMI)
27.7 kg/m^2
STANDARD_DEVIATION 6.1 • n=30 Participants

PRIMARY outcome

Timeframe: 360 minutes after ingestion

Determined by subtracting the cumulative urine output from the total fluid load consumed

Outcome measures

Outcome measures
Measure
Buoy Hydration Drops
n=30 Participants
Visit 1 consisted of the Buoy Hydration Drops beverage intervention at a dose containing 600mg/Litre of Na+ over 4 hours. All 30 participants completed visit 1.
Water Alone - Control
n=30 Participants
Visit 2 consisted of water alone as a control in which each subject ingested 1L of water at a rate of 6/25% of the calculated amount of water every 15 minutes for 4 hours. All 30 participants completed visit 2.
Nuun Sport Hydration Tabs
n=30 Participants
Visit 3 consisted of the Nunn Sport Hydration Tabs in which each subject consumed 1L of water with two dissolved tabs, containing 600mg of Na+ over 30 minutes. All 30 participants completed visit 3.
Net Fluid Balance
0.28 Liter
Standard Deviation 0.28
0.05 Liter
Standard Deviation 0.32
0.03 Liter
Standard Deviation 0.20

PRIMARY outcome

Timeframe: Urine will be measured during each visit (three total visits that each last 6 hours)

Sodium levels will be measured

Outcome measures

Outcome measures
Measure
Buoy Hydration Drops
n=30 Participants
Visit 1 consisted of the Buoy Hydration Drops beverage intervention at a dose containing 600mg/Litre of Na+ over 4 hours. All 30 participants completed visit 1.
Water Alone - Control
n=30 Participants
Visit 2 consisted of water alone as a control in which each subject ingested 1L of water at a rate of 6/25% of the calculated amount of water every 15 minutes for 4 hours. All 30 participants completed visit 2.
Nuun Sport Hydration Tabs
n=30 Participants
Visit 3 consisted of the Nunn Sport Hydration Tabs in which each subject consumed 1L of water with two dissolved tabs, containing 600mg of Na+ over 30 minutes. All 30 participants completed visit 3.
Electrolytes in Urine
39 milliequivalent/L (meq/L)
Standard Deviation 15
58 milliequivalent/L (meq/L)
Standard Deviation 21
48 milliequivalent/L (meq/L)
Standard Deviation 47

PRIMARY outcome

Timeframe: 360 minutes after ingestion

Osmolarity measures the concentration of solutes in urine. This is a key indicator of how concentrated or diluted the urine is, which directly reflects hydration status and kidney function. This can fluctuate depending on how much water the kidneys are excreting or retaining.

Outcome measures

Outcome measures
Measure
Buoy Hydration Drops
n=30 Participants
Visit 1 consisted of the Buoy Hydration Drops beverage intervention at a dose containing 600mg/Litre of Na+ over 4 hours. All 30 participants completed visit 1.
Water Alone - Control
n=30 Participants
Visit 2 consisted of water alone as a control in which each subject ingested 1L of water at a rate of 6/25% of the calculated amount of water every 15 minutes for 4 hours. All 30 participants completed visit 2.
Nuun Sport Hydration Tabs
n=30 Participants
Visit 3 consisted of the Nunn Sport Hydration Tabs in which each subject consumed 1L of water with two dissolved tabs, containing 600mg of Na+ over 30 minutes. All 30 participants completed visit 3.
Urine Osmolarity (mOsm/kg)
1928 milliOsm/kilogram (mOsm/kg)
Standard Deviation 544
1666 milliOsm/kilogram (mOsm/kg)
Standard Deviation 454
1866 milliOsm/kilogram (mOsm/kg)
Standard Deviation 318

SECONDARY outcome

Timeframe: 360-minutes after ingestion

Bio impedance measured through difference in body fat % pre- and post-urine

Outcome measures

Outcome measures
Measure
Buoy Hydration Drops
n=30 Participants
Visit 1 consisted of the Buoy Hydration Drops beverage intervention at a dose containing 600mg/Litre of Na+ over 4 hours. All 30 participants completed visit 1.
Water Alone - Control
n=30 Participants
Visit 2 consisted of water alone as a control in which each subject ingested 1L of water at a rate of 6/25% of the calculated amount of water every 15 minutes for 4 hours. All 30 participants completed visit 2.
Nuun Sport Hydration Tabs
n=30 Participants
Visit 3 consisted of the Nunn Sport Hydration Tabs in which each subject consumed 1L of water with two dissolved tabs, containing 600mg of Na+ over 30 minutes. All 30 participants completed visit 3.
Bio Impedance
0.75 percentage of body fat difference
Standard Deviation 0.62
0.64 percentage of body fat difference
Standard Deviation 0.65
0.44 percentage of body fat difference
Standard Deviation 0.32

Adverse Events

Buoy Hydration Drops

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Water Alone - Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Nuun Sport Hydration Tabs

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Harikesh Subramanian, MBBS, MS, D.ABA, ABPM-CI

University of Pittsburgh, UPMC

Phone: 412-647-9085

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place